Digital Therapeutics (DTx) is what the buzz is about and it is on the rise. This new subset of digital technology, used as a stand alone solution or to compliment medication and existing treatment, can bring a lot of promises. Is it the newest AND cheapest way to treat chronic conditions, or diseases not addressed by the current healthcare system? Is the future digital for therapy? Can we do a 180 degree turn on traditional ways?
In this session we will discuss the current state of DTx, the opportunities it can bring to pharma, payers, patients and healthcare professionals as well as the challenges to overcome for those solutions to become mainstream, with a special focus on reimbursement and clinical validation.